Cell line	Tissue Supergroup	Metastatic Tissue	Primary Tissue	Tissue Diagnosis	Age	Age Unit	Gender	Ethnicity	SNP Cluster Number	In Final Analysis Set	Growth Media	Freeze Media	CCLE ID	Sanger ID888	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	406	TRUE	#N/A	#N/A	NA	NA105KC	Sarcomatoid	NA	Cartilage	Chondrosarcoma	66	Years	Male	NA	271	FALSE	40%DMEM, 40%MEM, 10%F-12, 10% FBS, 100nM Hydrocortisone, 100ng/mL Insulin, 25ug/ml L-Ascorbic Acid	Complete growth medium, 90%; DMSO, 10%	NA	NA143B	Sarcomatoid	NA	Bone	Osteosarcoma	13	Years	Female	Caucasian	303	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	143B	NA23132/87	Stomach	NA	Stomach	Adenocarcinoma	72	Years	Male	NA	593	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	23132/87	23132-87501A	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	407	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NA	NA537 MEL	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	408	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NA59M	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	441	TRUE	DMEM, 10% FBS, 2mM Gln, 1mM NaP, 20IU/L Bovine Insulin	90% FBS; 10% DMSO	59M	NA624 mel	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	407	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NA769-P	Kidney	NA	Kidney	Adenocarcinoma	63	Years	Female	Caucasian	167	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	769-P	769-P786-O	Kidney	NA	Kidney	Adenocarcinoma	58	Years	Male	Caucasian	166	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	786-O	786-0928 mel	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	405	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAA-375	Skin		Skin	Melanoma	NA	NA	Female	NA	224	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A-375	A375A-427	Lung	NA	Lung	Carcinoma	52	Years	Male	Caucasian	512	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	A427A-431	Skin	NA	Skin	Carcinoma Squamous Cell	85	Years	Female	NA	129	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	A431A-498	Kidney	NA	Kidney	Carcinoma	52	NA	Female	NA	19	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A-498	A498A-673	Sarcomatoid	NA	Skeletal Muscle	Rhabdomyosarcoma	15	Years	Female	NA	171	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A-673	A673A172	Brain	NA	Brain	Glioblastoma	NA	NA	Male	NA	298	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	A172	A172A2058	Skin	NA	Skin	Melanoma	43	Years	Male	Caucasian	404	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A2058	A2058A2780	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	607	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete Growth Media, 90%; DMSO, 10%	A2780	A2780A3/KAW	Lymphoid	NA	Blood	Lymphoma	NA	NA	NA	NA	489	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A3/KAW	A3-KAWA4/Fuk	Lymphoid	NA	Blood	Lymphoma Non-Hodgkins	NA	NA	NA	NA	488	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A4/Fuk	A4-FukA549	Lung	NA	Lung	Carcinoma	58	Years	Male	Caucasian	371	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	A549	A549ABC-1	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	370	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	ABC-1	ABC-1ACHN	Kidney	NA	Kidney	Adenocarcinoma	22	Years	Male	Caucasian	252	TRUE	EMEM, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	ACHN	ACHNAGS	Stomach	NA	Stomach	Adenocarcinoma	NA	NA	NA	NA	599	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	AGS	AGSAMO-1	Lymphoid	NA	Blood	Plasmacytoma	NA	NA	NA	NA	384	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	AMO-1	NAAN3 CA	Uterus	NA	Uterus	Adenocarcinoma	55	Years	Female	Caucasian	196	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	AN3 CA	AN3-CAAsPC-1	Pancreas	NA	Pancreas	Adenocarcinoma	62	Years	Female	Caucasian	427	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% Complete Growth Media; 10% DMSO	AsPC-1	AsPC-1ATRFLOX	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	Male	NA	213	FALSE	McCoys 5A, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NABEN	Lung	NA	Lung	Carcinoma	71	Years	Male	NA	244	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BEN	BENBFTC-905	Urinary Bladder	NA	Urinary Bladder	Carcinoma Transitional Cell	51	Years	Female	Chinese	117	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BFTC-905	BFTC-905BFTC-909	Kidney	NA	Kidney	Carcinoma Transitional Cell	64	Years	Male	NA	251	TRUE	DMEM, 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	BFTC-909	BFTC-909BHY	Head-Neck	NA	Oral Cavity	Carcinoma Squamous Cell	NA	NA	NA	NA	257	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BHY	BHYBICR 10	Head-Neck	NA	Oral Cavity	Carcinoma Squamous Cell	NA	NA	NA	NA	170	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NABICR 22	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	NA	NA	NA	NA	217	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BICR 22	NABICR 31	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	NA	NA	NA	NA	199	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BICR 31	NABICR 78	Head-Neck	NA	Oral Cavity	Carcinoma Squamous Cell	NA	NA	NA	NA	74	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NABJAB	Lymphoid	NA	Lymph Node	Lymphoma B-cell	NA	NA	NA	NA	487	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	NA	NABT-20	Breast	NA	Breast	Carcinoma	74	Years	Female	Caucasian	569	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BT-20	BT-20BT-474	Breast	Soft Tissue	Breast	Adenocarcinoma Ductal	60	Years	Female	Caucasian	568	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BT-474	NABT-483	Breast	NA	Breast	Adenocarcinoma Ductal	23	Years	Female	Caucasian	567	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BT-483	NABT-549	Breast	NA	Breast	Adenocarcinoma Ductal	72	Years	Female	Caucasian	566	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BT-549	BT-549BxPC-3	Pancreas	NA	Pancreas	Adenocarcinoma	61	Years	Female	NA	325	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	BxPC-3	BxPC-3C-33 A	Cervix	NA	Cervix	Carcinoma	NA	NA	NA	NA	193	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	C-33-AC170	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	523	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAC2BBe1	Colo-Rectal	NA	Colon	Adenocarcinoma	72	Years	Male	Caucasian	264	TRUE	DMEM; 10% FBS; 2mM L-Glutamine	90% FBS; 10% DMSO	C2BBe1	C2BBe1C32	Skin	NA	Skin	Melanoma	53	Years	Male	Caucasian	73	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	C32	C32C32TG	Skin	NA	Skin	Melanoma	53	Years	Male	Caucasian	73	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAC3A	Liver	NA	Liver	Carcinoma	NA	NA	NA	NA	72	FALSE	#N/A	#N/A	C3A	C3ACa Ski	Cervix	NA	Cervix	Carcinoma	NA	NA	NA	NA	269	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	Ca-SkiCA46	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	NA	NA	Male	NA	486	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CA46	CA46Caco-2	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	264	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACaki-1	Kidney	NA	Kidney	Adenocarcinoma Clear Cell	49	Years	Male	Caucasian	211	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Caki-1	CAKI-1Caki-2	Kidney	NA	Kidney	Carcinoma	69	Years	Male	Caucasian	165	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	Caki-2	NACAL 27	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	56	Years	Male	Caucasian	120	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CAL 27	CAL-27CAL 54	Kidney	NA	Kidney	Carcinoma	NA	NA	NA	NA	210	TRUE	DMEM, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	CAL-54	CAL-54CAL-120	Breast	Effusion, Pleural	Breast	Adenocarcinoma	43	Years	Female	NA	565	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CAL-120	CAL-120CAL-12T	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	Male	NA	243	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CAL-12T	CAL-12TCAL-148	Breast	Effusion, Pleural	Breast	Adenocarcinoma	58	Years	Female	NA	564	TRUE	RPMI-1640, 10% FBS, 10ng/ml EGF, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CAL-148	CAL-148CAL-85-1	Breast	NA	Breast	Adenocarcinoma	35	Years	Female	NA	563	TRUE	DMEM, 10% FBS, 2mM L-glutamine	Complete growth medium, 90%; DMSO, 10%	CAL-85-1	CAL-85-1CAL51	Breast	Effusion, Pleural	Breast	Adenocarcinoma	45	Years	Female	NA	351	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CAL-51	CAL-51Calu-1	Lung	NA	Lung	Carcinoma	47	Years	Female	Caucasian	NA	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Calu-1	Calu-1Calu-3	Lung	NA	Lung	Adenocarcinoma	25	Years	Male	Caucasian	511	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Calu-3	Calu-3Calu-6	Lung	NA	Lung	Carcinoma Anaplastic	61	Years	Female	Caucasian	510	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Calu-6	Calu-6CAMA-1	Breast	NA	Breast	Adenocarcinoma	51	Years	Female	Caucasian	562	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete Growth media, 10% DMSO	CAMA-1	CAMA-1Caov-3	Ovary	NA	Ovary	Adenocarcinoma	54	Years	Female	Caucasian	NA	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	Caov-3	Caov-3Capan-1	Pancreas	NA	Pancreas	Adenocarcinoma	40	Years	Male	Caucasian	426	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	Capan-1	CAPAN-1Capan-2	Pancreas	NA	Pancreas	Adenocarcinoma	56	Years	Male	Caucasian	425	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	Capan-2	Capan-2CaR-1	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	24	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	CaR-1CCRF-SB	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	NA	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACFPAC-1	Pancreas	NA	Pancreas	Adenocarcinoma Ductal	NA	NA	Male	Caucasian	424	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	CFPAC-1	CFPAC-1ChaGo-K-1	Lung	NA	Lung	Carcinoma	45	Years	Male	NA	242	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	ChaGo-K-1	ChaGo-K-1CHL-1	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	241	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CHL-1	CHL-1CHP-212	Brain	NA	Brain	Neuroblastoma	NA	NA	NA	NA	297	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	CHP-212	CHP-212CI-1	Lymphoid	NA	Lymph Node	Lymphoma Non-Hodgkins	38	Years	Female	NA	485	TRUE	RPMI-1640, 20% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	CI-1	NACL-11	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	529	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CL-11	NACL-34	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Female	NA	528	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS, 10% DMSO	CL-34	NACL-40	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Female	NA	527	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CL-40	NACOLO 201	Colo-Rectal	NA	Colon	Adenocarcinoma	70	Years	Male	Caucasian	263	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO 201	NACOLO 205	Colo-Rectal	Ascites	Colon	Adenocarcinoma	70	Years	Male	Caucasian	263	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO 205	COLO-205COLO 206F	Colo-Rectal	NA	Colon	Adenocarcinoma	70	Years	Male	NA	263	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOLO 320DM	Colo-Rectal	NA	Colon	Carcinoma	55	Years	Female	Caucasian	526	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOLO 678	Colo-Rectal	NA	Colon	Carcinoma	69	Years	Male	NA	524	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO-678	COLO-678COLO 679	Skin	NA	Skin	Melanoma	47	Years	Female	NA	606	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO-679	COLO-679COLO 680N	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	57	Years	Female	African	30	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO-680N	COLO-680NCOLO 699	Lung	NA	Lung	Adenocarcinoma	57	Years	Female	NA	241	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOLO 741	Colo-Rectal	NA	Colon	Carcinoma	69	Years	NA	NA	525	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% Complete Growth Media, 10% DMSO	COLO 741	COLO-741COLO 792	Skin	NA	Skin	Melanoma	62	Years	Male	NA	45	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO 792	COLO-792COLO 794	Skin	NA	Skin	Melanoma	14	Years	Male	NA	71	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOLO 800	Skin	NA	Skin	Melanoma	14	Years	Male	NA	71	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO-800	COLO-800COLO 829	Skin	NA	Skin	Melanoma	45	Years	Male	Caucasian	70	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO 829	NACOLO 849	Skin	Lymph Node	Skin	Melanoma Metastatic	43	Years	Male	Caucasian	NA	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	COLO-849	NACOLO 853	Skin	NA	Skin	Melanoma	43	Years	Male	NA	70	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOLO 857	Skin	NA	Skin	Melanoma	43	Years	Male	NA	70	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOLO-704	Ovary	NA	Ovary	Adenocarcinoma	46	Years	Female	Caucasian	140	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	COLO-704	NACOLO-783	Skin	Lymph Node	Skin	Melanoma Metastatic	48	Years	Female	NA	201	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COLO-783	NACOLO-818	Skin	NA	Skin	Melanoma Metastatic	NA	NA	NA	NA	71	FALSE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	NA	NACOR-L26	Lung	NA	Lung	Carcinoma Large Cell	NA	NA	Female	NA	157	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOR-L279	Lung	NA	Lung	Carcinoma Small Cell	63	Years	Male	NA	192	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COR-L279	COR-L279COR-L47	Lung	NA	Lung	Carcinoma Small Cell	67	Years	Male	Caucasian	99	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COR-L47	NACOR-L88	Lung	NA	Lung	Carcinoma Small Cell	55	Years	Male	Caucasian	98	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COR-L88	COR-L88COV318	Ovary	Ascites	Ovary	Carcinoma	NA	NA	NA	NA	228	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COV318	NACOV362	Ovary	Pleura	Ovary	Carcinoma	NA	NA	NA	NA	206	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COV362	NACOV413A	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	205	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOV413B	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	205	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NACOV434	Ovary	NA	Ovary	Tumor Granulosa Cell	NA	NA	Female	NA	227	TRUE	DMEM; 10% FBS; 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COV434	NACOV504	Ovary	Pleura	Ovary	Carcinoma	NA	NA	NA	NA	204	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COV504	NACOV644	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	112	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	COV644	NACPC-N	Lung	NA	Lung	Carcinoma Small Cell	NA	NA	NA	NA	97	TRUE	McCoys 5A, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CPC-N	CPC-NCW-2	Colo-Rectal	NA	Colon	Carcinoma	45	Years	Female	Japanese	22	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	CW-2	CW-2CX-1	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	172	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NADAN-G	Pancreas	NA	Pancreas	Adenocarcinoma	NA	NA	NA	NA	324	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DAN-G	NADaudi	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	NA	NA	NA	NA	583	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	Daudi	DaudiDB	Lymphoid	NA	Lymph Node	Lymphoma B-cell	45	Years	Male	Caucasian	484	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	Complete Growth Media, 90%; DMSO, 10%	DB	DBDEOC-1	Skin	NA	Skin	Melanoma	59	Years	Male	Japanese	NA	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NADetroit 562	Head-Neck	NA	Nasal Pharynx	Carcinoma	NA	NA	Female	Caucasian	169	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; DMSO, 10%	Detroit 562	Detroit562DLD-1	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Male	NA	523	FALSE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DLD-1	NADMS 273	Lung	NA	Lung	Carcinoma Small Cell	50	Years	Female	NA	156	TRUE	Waymouth's MB 752/1 medium, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DMS 273	DMS-273DMS 454	Lung	NA	Lung	Carcinoma Small Cell	NA	NA	Male	NA	48	TRUE	Waymouth's MB 752/1 medium, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DMS 454	NADMS 53	Lung	NA	Lung	Carcinoma Small Cell	54	Years	Male	Caucasian	5	TRUE	Waymouth's MB 752/1 medium, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DMS 53	DMS-53DMS 79	Lung	NA	Lung	Carcinoma Small Cell	65	Years	NA	Caucasian	191	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DMS 79	DMS-79DOHH-2	Lymphoid	Effusion, Pleural	Lymph Node	Lymphoma B-cell	60	Years	Male	NA	483	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	90% Complete growth medium; 10% DMSO	DOHH-2	DOHH-2DOK	Head-Neck	NA	Tongue	Dysplasia	NA	NA	NA	NA	198	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	DOKDOR 13	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	440	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NADU 145	Other	NA	Prostate	Carcinoma	69	Years	Male	Caucasian	134	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DU 145	DU-145DU4475	Breast	NA	Breast	Carcinoma	70	Years	Female	Caucasian	103	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DU4475	DU-4475DV-90	Lung	NA	Lung	Adenocarcinoma	50	Years	Male	NA	240	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	DV-90	DV-90EB-3	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	3	Years	Male	African	482	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	EB-3EB1	Lymphoid	NA	Lymph Node	Malignant Lymphoma - Burkitts Type	NA	NA	NA	NA	104	FALSE	RPMI-1640 10% HI FBS, 2mM Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	EB1	NAEB2	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	7	Years	Female	African	104	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EB2	EB2EBC-1	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	509	TRUE	RPMI-1640, 10% TET Free FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EBC-1	NAEFM-19	Breast	Effusion, Pleural	Breast	Carcinoma	50	Years	Female	Caucasian	561	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EFM-19	EFM-19EFM-192A	Breast	NA	Breast	Adenocarcinoma	46	Years	Female	Caucasian	102	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EFM-192A	NAEFM-192B	Breast	NA	Breast	Adenocarcinoma	46	Years	Female	Caucasian	102	FALSE	RPMI-1640, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAEFM-192C	Breast	NA	Breast	Adenocarcinoma	46	Years	Female	Caucasian	102	FALSE	RPMI-1640, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAEFO-27	Ovary	NA	Ovary	Adenocarcinoma	36	Years	Female	NA	439	TRUE	80% RPMI 1640 + 20% FBS + 2 mM L-glutamine + 1x MEM non-essential amino acids + 1 mM sodium pyruvate	FBS, 90%; DMSO, 10%	EFO-27	EFO-27EJM	Lymphoid	Peritoneum	Blood	Multiple Myeloma	58	Years	Female	NA	375	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EJM	NAEKVX	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	508	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	EKVXEPLC-272H	Lung	NA	Lung	Carcinoma	57	Years	Male	Caucasian	239	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EPLC-272H	EPLC-272HES-2	Ovary	NA	Ovary	Adenocarcinoma Clear Cell	47	Years	Female	African	438	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	ES-2	NAEVSA-T	Breast	Ascites	Breast	Carcinoma	NA	NA	NA	NA	560	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	EVSA-T	EVSA-TFaDu	Head-Neck	NA	Nasal Pharynx	Carcinoma Squamous Cell	NA	NA	NA	NA	256	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	FaDu	FADUFarage	Lymphoid	NA	Blood	Lymphoma Non-Hodgkins	NA	NA	NA	NA	481	TRUE	#N/A	#N/A	NA	NAFU97	Stomach	NA	Stomach	Adenocarcinoma	66	Years	Male	Japanese	585	TRUE	DMEM, 10% FBS and 10mg/L insulin	Complete growth medium, 90%; DMSO, 10%	FU97	NAG-361	Skin	NA	Skin	Melanoma	31	Years	Male	Caucasian	403	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	G-361	G-361G-402	Kidney	NA	Kidney	Leiomyoma	9	Months	Female	NA	164	TRUE	McCoy's 5a, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	G-402	NAG111	Brain	NA	Brain	Glioma	NA	NA	NA	NA	296	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAG112	Brain	NA	Brain	Glioma	NA	NA	NA	NA	293	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG118	Brain	NA	Brain	Glioma	NA	NA	NA	NA	176	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAG120	Brain	NA	Brain	Glioma	NA	NA	NA	NA	295	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG121	Brain	NA	Brain	Glioma	NA	NA	NA	NA	294	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NA	NAG122	Brain	NA	Brain	Glioma	NA	NA	NA	NA	293	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS 90%; DMSO, 10%	NA	NAG124	Brain	NA	Brain	Glioma	NA	NA	NA	NA	292	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS 90%; DMSO, 10%	NA	NAG130	Brain	NA	Brain	Glioma	NA	NA	NA	NA	291	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAG140	Brain	NA	Brain	Glioma	NA	NA	NA	NA	290	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG141	Brain	NA	Brain	Glioma	NA	NA	NA	NA	176	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAG142	Brain	NA	Brain	Glioma	NA	NA	NA	NA	176	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG22	Brain	NA	Brain	Glioma	NA	NA	NA	NA	289	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAG28T	Brain	NA	Brain	Glioma	NA	NA	NA	NA	288	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG44	Brain	NA	Brain	Glioma	NA	NA	NA	NA	284	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG59	Brain	NA	Brain	Glioma	NA	NA	NA	NA	287	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG61	Brain	NA	Brain	Glioma	NA	NA	NA	NA	286	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAG84	Brain	NA	Brain	Glioma	NA	NA	NA	NA	285	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAG96	Brain	NA	Brain	Glioma	NA	NA	NA	NA	284	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAGA-10	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	41	Years	Male	Caucasian	480	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	GA-10	NAGP2d	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	44	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	GP2d	Gp2DGP5d	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	44	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	GP5dGR-M	Skin	NA	Skin	Melanoma	36	Years	Male	Caucasian	69	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	GR-M	NAGRANTA-519	Lymphoid	NA	Lymph Node	Lymphoma B-cell	58	Years	Female	Caucasian	479	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	GRANTA-519	NAGTL-16	Stomach	NA	Stomach	Adenocarcinoma	62	Years	Female	NA	514	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NA	NAH322T	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	145	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHBL-100	Breast	NA	Breast	Normal	27	Years	Female	Caucasian	336	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCA-7	Colo-Rectal	NA	Colon	Adenocarcinoma	58	Years	Female	NA	262	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC-15	Lung	NA	Lung	Carcinoma Non-Small Cell	48	Years	Male	NA	502	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-15	NAHCC1011	Kidney	NA	Kidney	Carcinoma Renal Cell	37	Years	Male	Hispanic	209	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1143	Breast	NA	Breast	Adenocarcinoma Ductal	52	Years	Female	Caucasian	559	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1143	HCC1143HCC1162	Uterus	NA	Uterus	Adenocarcinoma	NA	NA	NA	NA	107	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1171	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	155	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-1171	NAHCC1187	Breast	Soft Tissue	Breast	Adenocarcinoma Ductal	41	Years	Female	Caucasian	558	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1187	HCC1187HCC12	Kidney	NA	Kidney	Carcinoma Renal Cell	45	Years	Female	NA	208	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1263	Colo-Rectal	NA	Colon	Adenocarcinoma	20	Years	Female	African	115	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1319	Kidney	NA	Kidney	Carcinoma Renal Cell	68	Years	Male	Caucasian	113	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1359	Lung	NA	Lung	Carcinoma Large Cell	NA	NA	NA	NA	190	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-1359	NAHCC1395	Breast	NA	Breast	Adenocarcinoma Ductal	43	Years	Female	Caucasian	557	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1395	HCC1395HCC1419	Breast	NA	Breast	Adenocarcinoma Ductal	42	Years	Female	Hispanic	556	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1419	HCC1419HCC1428	Breast	Effusion, Pleural	Breast	Adenocarcinoma	49	Years	Female	Caucasian	555	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1428	NAHCC1482	Uterus	NA	Uterus	Adenocarcinoma	62	Years	Female	Caucasian	195	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1493	Breast	NA	Breast	Adenocarcinoma	43	Years	Male	NA	194	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1500	Breast	NA	Breast	Adenocarcinoma Ductal	32	Years	Female	African	554	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1500	NAHCC1534	Lung	NA	Lung	Unknown	NA	NA	NA	NA	189	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1569	Breast	NA	Breast	Carcinoma Metaplastic	70	Years	Female	African	553	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1569	NAHCC1576	Other	NA	Adrenal	Unknown	NA	NA	NA	NA	68	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1599	Breast	NA	Breast	Adenocarcinoma Ductal	44	Years	Female	Caucasian	552	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	HCC1599	HCC1599HCC1806	Breast	NA	Breast	Carcinoma Squamous Cell	60	Years	Female	African	551	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth media, 10% DMSO	HCC1806	HCC1806HCC193	Lung		Lung	Adenocarcinoma	71	Years	Female	Caucasian	8	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC1937	Breast	Soft Tissue	Breast	Adenocarcinoma Ductal	23	Years	Female	Caucasian	550	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1937	HCC1937HCC1954	Breast	Soft Tissue	Breast	Adenocarcinoma Ductal	61	Years	Female	East Indian	549	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC1954	HCC1954HCC202	Breast	NA	Breast	Adenocarcinoma Ductal	82	Years	NA	Caucasian	548	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC202	NAHCC2157	Breast	NA	Breast	Adenocarcinoma Ductal	48	Years	Female	African	268	FALSE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	HCC2157	HCC2157HCC2218	Breast	Soft Tissue	Breast	Adenocarcinoma Ductal	38	Years	Female	Caucasian	547	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC2218	HCC2218HCC2270	Lung	NA	Lung	Adenocarcinoma	64	Years	Female	Caucasian	188	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC2279	Lung	NA	Lung	Adenocarcinoma	52	Years	Female	NA	346	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-2279	NAHCC2302	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	96	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC2688	Breast	NA	Breast	Adenocarcinoma Ductal	NA	NA	Female	NA	382	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC2885	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	187	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC2911	Breast	NA	Breast	Carcinoma	NA	NA	NA	NA	335	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC2935	Lung	NA	Lung	Adenocarcinoma	39	Years	Male	Caucasian	368	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	HCC2935	NAHCC33	Lung	NA	Lung	Carcinoma Small Cell	53	Years	Male	Caucasian	4	TRUE	RPMI-1640, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-33	NAHCC364	Lung	NA	Lung	Adenocarcinoma	76	Years	Male	NA	154	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC364	NAHCC366	Lung	NA	Lung	Carcinoma Non-Small Cell	80	Years	Female	NA	95	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-366	NAHCC38	Breast	Soft Tissue	Breast	Adenocarcinoma Ductal	50	Years	Female	Caucasian	546	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC38	HCC38HCC4006	Lung	NA	Lung	Adenocarcinoma	50	Years	Male	Caucasian	345	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC4006	NAHCC4011	Lung	NA	Lung	Adenocarcinoma	53	Years	Male	Caucasian	367	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC4017	Lung	NA	Lung	Carcinoma Large Cell	NA	NA	NA	NA	153	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC44	Lung	NA	Lung	Carcinoma Non-Small Cell	54	Years	Female	NA	238	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-44	NAHCC461	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	56	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC515	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	152	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC60	Ovary	NA	Ovary	Carcinoma	26	Years	Female	African	226	FALSE	#N/A	#N/A	NA	NAHCC630	Ovary	NA	Ovary	Carcinoma	32	Years	Female	Hispanic	203	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCC70	Breast	NA	Breast	Adenocarcinoma Ductal	49	Years	Female	African	545	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC70	HCC70HCC78	Lung	NA	Lung	Adenocarcinoma	65	Years	Male	NA	237	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC-78	NAHCC827	Lung	NA	Lung	Adenocarcinoma	NA	NA	Female	Caucasian	366	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCC827	NAHCC89	Kidney	NA	Kidney	Carcinoma Renal Cell	64	Years	Female	Caucasian	207	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHCT 116	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	Male	NA	213	TRUE	McCoys 5A,  10% FBS, 2mM L-glutamine	50% FBS, 40% media, 10% DMSO	HCT 116	HCT-116HCT-15	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Male	NA	523	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS, 10% DMSO	HCT-15	HCT-15HCT-8	Colo-Rectal	NA	Ileum	Adenocarcinoma	NA	NA	NA	NA	523	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HCT-8	NAHEC-1-A	Uterus	Endometrium	Uterus	Adenocarcinoma	71	Years	Female	NA	106	TRUE	McCoys 5A, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HEC-1-A	NAHEL	Lymphoid	NA	Blood	Erythroleukemia	30	Years	Male	NA	582	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	HEL	HELHeLa	Cervix	NA	Cervix	Adenocarcinoma	NA	NA	Female	African	268	TRUE	EMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	HeLaSFHep G2	Liver	NA	Liver	Carcinoma Hepatocellular	15	Years	Male	Caucasian	72	TRUE	EMEM ATCC, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hep G2	NAHEp-2	Cervix	NA	Cervix	Adenocarcinoma	NA	NA	NA	NA	268	FALSE	EMEM, 10% FBS, 2mM Glutamine	90% FBS, 10% DMSO	NA	NAHEY	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	437	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS ; 10% DMSO	Hey-A8	NAHGC-27	Stomach	NA	Stomach	Carcinoma	NA	NA	NA	NA	67	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HGC-27	HGC-27HL-60	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	12	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HL-60	HL-60HM7	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	175	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS, 10% DMSO	NA	NAHMY-1	Skin	NA	Skin	Melanoma	62	Years	Male	Japanese	66	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHN	Head-Neck	NA	Oral Cavity	Carcinoma Squamous Cell	NA	NA	NA	NA	255	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HN	HNHNT-34	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	47	Years	Female	NA	581	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHOP-62	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	365	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	HOP-62HOP-92	Lung	NA	Lung	Carcinoma Large Cell	NA	NA	NA	NA	344	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	HOP-92HPAC	Pancreas	NA	Pancreas	Adenocarcinoma	64	Years	Female	Caucasian	322	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	HPAC	NAHPAF-II	Pancreas	NA	Pancreas	Adenocarcinoma	NA	NA	Male	Caucasian	423	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	HPAF-II	HPAF-IIHs 255.T	Colo-Rectal	NA	Colon	Adenocarcinoma	46	Years	Female	Caucasian	114	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 255.T	NAHs 294T	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	223	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 294T	NAHs 38.T	Ovary	NA	Ovary	Teratoma	NA	NA	Female	NA	14	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHs 578T	Breast	NA	Breast	Carcinoma	74	Years	Female	Caucasian	544	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 578T	Hs-578-THs 675.T	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	Male	Caucasian	16	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 675.T	NAHs 683	Brain	NA	Brain	Glioma	NA	NA	NA	NA	283	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	Hs 683	NAHs 695T	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	128	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 695T	NAHs 69ST	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	128	FALSE	#N/A	#N/A	NA	NAHs 746T	Stomach	NA	Stomach	Carcinoma	NA	NA	NA	NA	594	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 746T	NAHs 766T	Pancreas	NA	Pancreas	Carcinoma	46	Years	Male	Caucasian	422	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	Hs 766T	NAHs 839.T	Skin	NA	Skin	Melanoma	42	Years	Female	Caucasian	111	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	Hs 839.T	NAHs 852.T	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	605	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 852.T	NAHs 895.T	Skin	NA	Skin	Melanoma	48	Years	Female	Caucasian	110	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Hs 895.T	NAHs 936.T	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	600	TRUE	#N/A	#N/A	Hs 936.T	NAHs 940.T	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	402	TRUE	#N/A	#N/A	Hs 940.T	NAHS-Sultan	Lymphoid	NA	Blood	Lymphoma	7	Years	Male	African	476	FALSE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAHT	Lymphoid	Ascites	Lymph Node	Lymphoma Diffuse Mixed	70	Years	Male	Caucasian	478	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	90% Complete Growth Media; 10% DMSO	HT	HTHT-1080	Lung	NA	Lung	Fibrosarcoma	35	Years	Male	Caucasian	151	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	HT-1080	HT-1080HT-115	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	43	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HT115	NAHT-144	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	401	TRUE	#N/A	#N/A	HT-144	HT-144HT-29	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Female	Caucasian	172	TRUE	McCoys 5A, 10% FBS, 2mM L-Glutamine	50% FBS, 40% media, 10% DMSO	HT-29	HT-29HT-55	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	261	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HT55	HT55huH-1	Liver	NA	Liver	Carcinoma Hepatocellular	53	Years	Male	Japanese	250	TRUE	DMEM, 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	huH-1	NAHuH-7	Liver	NA	Liver	Carcinoma Hepatocellular	57	Years	Male	Japanese	162	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine 	90% FBS; 10% DMSO	HuH-7	HuH-7HUP-T3	Pancreas	NA	Pancreas	Adenocarcinoma	66	Years	Male	Japanese	421	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HUP-T3	HuP-T3HUP-T4	Pancreas	Ascites	Pancreas	Carcinoma	60	Years	Male	Japanese	323	TRUE	EMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	HUP-T4	HuP-T4IGR-37	Skin	NA	Skin	Melanoma	26	Years	Male	NA	65	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	IGR-37	NAIGROV-1	Ovary	NA	Ovary	Carcinoma	47	Years	Female	NA	139	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	IGROV1	IGROV-1IM-95	Stomach	NA	Stomach	Adenocarcinoma	NA	NA	NA	NA	34	TRUE	DMEM, 10% FBS, 10mg/L Insulin, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	IM95	NAIM-95m	Stomach	NA	Stomach	Adenocarcinoma	63	Years	Male	Japanese	34	FALSE	DMEM, 10% FBS, 10mg/L Insulin, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAIMR-32	Brain	NA	Brain	Neuroblastoma	1	Years	Male	Caucasian	282	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	IMR-32	NAIPC-298	Skin	NA	Skin	Melanoma	64	Years	Female	NA	604	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	IPC-298	IPC-298JEKO-1	Lymphoid	NA	Lymph Node	Lymphoma	78	Years	Female	NA	477	TRUE	RPMI-1640 , 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JeKo-1	NAJHH-1	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	64	TRUE	Williams Media E, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JHH-1	NAJHH-2	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	161	TRUE	Williams Media E, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JHH-2	NAJHH-4	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	63	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JHH-4	NAJHH-5	Liver	NA	Liver	Carcinoma Hepatocellular	50	Years	Male	NA	160	TRUE	Williams Media E, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JHH-5	NAJHH-7	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	159	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JHH-7	NAJIMT-1	Breast	Effusion, Pleural	Breast	Adenocarcinoma Ductal	62	Years	Female	NA	543	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JIMT-1	NAJiyoye	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	7	Years	Male	African	476	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	JiyoyeP-2003JJ012	Sarcomatoid	NA	Cartilage	Chondrosarcoma	NA	NA	NA	NA	271	TRUE	40%DMEM, 40%MEM, 10%F-12, 10% FBS, 100nM Hydrocortisone, 100ng/mL Insulin, 25ug/ml L-Ascorbic Acid	Complete growth medium, 90%; DMSO, 10%	NA	NAJJN-3	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	369	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JJN-3	NAJL-1	Other	NA	Pleura	Mesothelioma	54	Years	Male	NA	15	TRUE	DMEM, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	JL-1	NAJurkat, Clone E6-1	Lymphoid	NA	Blood	Leukemia Acute Lymphocytic	NA	NA	Male	NA	308	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAK-562	Lymphoid	NA	Blood	Leukemia Chronic Myelogenic	NA	NA	NA	NA	307	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	K-562	NAKARPAS-1106P	Lymphoid	NA	Lymph Node	Lymphoma B-cell	23	Years	NA	NA	475	TRUE	RPMI-1640, 20% HI FBS, 2mM Glutamine	RPMI-1640 70% 20% HI FBS, DMSO, 10%	NA	NAKARPAS-422	Lymphoid	NA	Blood	Lymphoma Non-Hodgkins	NA	NA	NA	NA	474	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	HI FBS, 90%; DMSO, 10%	KARPAS-422	KARPAS-422KARPAS-620	Lymphoid	NA	Blood	Leukemia	77	Years	Female	NA	350	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KARPAS-620	NAKasumi-1	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	13	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KASUMI-1	KASUMI-1KATO III	Stomach	NA	Stomach	Carcinoma	NA	NA	NA	NA	220	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KATO III	KATOIIIKCI-MOH1	Pancreas	NA	Pancreas	Adenocarcinoma	74	Years	Male	African	322	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KCI-MOH1	NAKELLY	Brain	NA	Brain	Neuroblastoma	NA	NA	NA	NA	281	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KELLY	NAKG-1	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	580	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KG-1	NAKHM-1B	Lymphoid	NA	Blood	Multiple Myeloma	NA	NA	NA	NA	309	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KHM-1B	NAKLE	Uterus	NA	Uterus	Adenocarcinoma	64	Years	Female	Caucasian	105	TRUE	DMEM:F12, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KLE	NAKLM-1	Pancreas	NA	Pancreas	Carcinoma	NA	NA	NA	NA	321	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KLM-1	NAKM-12	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	522	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KM12	KM12KMM-1	Lymphoid	NA	Blood	Multiple Myeloma	62	Years	Male	Japanese	364	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMM-1	NAKMS-11	Lymphoid	NA	Blood	Multiple Myeloma	NA	NA	NA	NA	359	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-11	NAKMS-12-BM	Lymphoid	NA	Blood	Multiple Myeloma	64	Years	Female	NA	353	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-12-BM	KMS-12-BMKMS-12-PE	Lymphoid	NA	Bone Marrow	Multiple Myeloma	64	Years	Female	NA	353	FALSE	RPMI-1640, 20% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	KMS-12-PEKMS-21BM	Lymphoid	NA	Blood	Multiple Myeloma	62	Years	Male	Japanese	383	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-21BM	NAKMS-26	Lymphoid	NA	Blood	Multiple Myeloma	NA	NA	NA	NA	310	TRUE	RPMI-1640, 10% Heat Inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-26	NAKMS-27	Lymphoid	NA	Blood	Multiple Myeloma	52	Years	Male	Japanese	349	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-27	NAKMS-28BM	Lymphoid	Bone Marrow	Blood	Multiple Myeloma	77	Years	Female	Japanese	381	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-28BM	NAKMS-28PE	Lymphoid	Pleura	Blood	Multiple Myeloma	77	Years	Female	Japanese	381	FALSE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAKMS-34	Lymphoid	Pleura	Blood	Multiple Myeloma	60	Years	Female	Japanese	380	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KMS-34	NAKNS-62	Lung	NA	Lung	Carcinoma Non-Small Cell	49	Years	Male	NA	501	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KNS-62	KNS-62KP-2	Pancreas	NA	Pancreas	Carcinoma	NA	NA	NA	NA	320	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KP-2	NAKP-3	Pancreas	NA	Pancreas	Carcinoma Adenosquamous	75	Years	Male	Japanese	319	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KP-3	NAKP4	Pancreas	NA	Pancreas	Carcinoma In Situ Ductal	50	Years	Male	NA	420	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% Complete Growth Media; 10% DMSO	KP4	KP-4KPL-1	Breast	NA	Breast	Adenocarcinoma Ductal	NA	NA	Female	NA	541	FALSE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KPL-1	NAKPL-4	Breast	Effusion, Pleural	Breast	Adenocarcinoma Ductal	52	Years	Female	Japanese	542	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAKU812	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	62	TRUE	RPMI-1640, 10% Heat Inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KU812	NAKURAMOCHI	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	50	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KURAMOCHI	KURAMOCHIKYSE-140	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	50	Years	Male	Japanese	32	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-140	KYSE-140KYSE-150	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	49	Years	Female	Japanese	27	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-150	KYSE-150KYSE-180	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	53	Years	Male	Japanese	39	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-180	KYSE-180KYSE-270	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	79	Years	Male	Japanese	35	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-270	KYSE-270KYSE-30	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	64	Years	Male	Japanese	46	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-30	NAKYSE-450	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	59	Years	Male	Japanese	33	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-450	KYSE-450KYSE-510	Head-Neck		Esophagus	Carcinoma Squamous Cell	67	Years	Female	Japanese	26	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-510	KYSE-510KYSE-520	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	58	Years	Female	Japanese	42	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-520	KYSE-520KYSE-70	Head-Neck	NA	Esophagus	Carcinoma Squamous Cell	77	Years	Male	Japanese	49	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	KYSE-70	KYSE-70L-363	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	379	TRUE	RPMI-1640, 10% Heat Inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	L-363	L-363LCLC-103H	Lung	NA	Lung	Carcinoma Large Cell	61	Years	Male	Caucasian	236	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LCLC-103H	LCLC-103HLCLC-97TM1	Lung	NA	Lung	Carcinoma Large Cell	44	Years	Male	Caucasian	150	TRUE	RPMI-1640, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LCLC-97TM1	LCLC-97TM1LN-18	Brain	NA	Brain	Glioma	NA	NA	NA	NA	280	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	LN-18	NALN-229	Brain	NA	Brain	Glioma	NA	NA	NA	NA	279	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	LN-229	NALNCAP	Other	NA	Prostate	Carcinoma	50	Years	Male	Caucasian	202	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LNCaP clone FGC	LNCaP-Clone-FGCLOU-NH91	Lung	NA	Lung	Carcinoma Squamous Cell	64	Years	Female	NA	94	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LOU-NH91	NALoVo	Colo-Rectal	NA	Colon	Adenocarcinoma	56	Years	Male	Caucasian	521	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LoVo	LoVoLOX-IMVI	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	127	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LOX IMVI	LOXIMVILP-1	Lymphoid	NA	Blood	Multiple Myeloma	56	Years	Female	NA	378	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LP-1	LP-1LS 174T	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	175	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	LS-174TLS 180	Colo-Rectal	NA	Colon	Adenocarcinoma	58	Years	Female	Caucasian	175	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	LS 180	NALS1034	Colo-Rectal	NA	Cecum	Carcinoma	54	Years	NA	Caucasian	270	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	 90% FBS; 10% DMSO	LS1034	LS-1034LXF-289	Lung	NA	Lung	Adenocarcinoma	63	Years	Male	NA	235	TRUE	Ham's F10, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	LXF-289	LXF-289LXFL529	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	390	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAM059J	Brain	NA	Brain	Glioblastoma	33	Years	Male	NA	116	FALSE	DMEM/F12, 10% FBS, 2mM L-Glutamine, 15mM HEPES, 0.5mM Na.pyr, 1.2g/L NaHCO3, 0.5mM NEAA	Complete growth medium, 90%; DMSO, 10%	NA	M059JM059K	Brain	NA	Brain	Glioblastoma	33	Years	Male	NA	116	TRUE	DMEM/F12, 10% FBS, 2mM L-Glutamine, 15mM HEPES, 0.5mM Na.pyr, 1.2g/L NaHCO3, 0.5mM NEAA	Complete growth medium, 90%; DMSO, 10%	M059K	NAMC116	Lymphoid	Ascites	Lymph Node	Lymphoma	NA	NA	NA	NA	473	TRUE	RPMI-1640 20% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	MC116	NAMCAS	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	NA	NA	51	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MCAS	NAMCF 10A	Breast	NA	Breast	Fibrocystic Disease	NA	NA	Female	Caucasian	177	TRUE	DMEM/F12, 2% Charcoal dextran treated FBS, 20ng/ml EGF, 0.01 mg/ml insulin, 500ng/ml Hydrocortisone	50% FBS, 40% complete media, 10% DMSO	NA	NAMCF-7	Breast	Effusion, Pleural	Breast	Adenocarcinoma	40	Years	Female	Caucasian	541	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MCF7	MCF7MCF10DCIS.com	Breast	NA	Breast	Normal	NA	NA	NA	NA	177	FALSE	DMEM/F12, 2% Charcoal dextran treated FBS, 20ng/ml EGF, 0.01 mg/ml insulin, 500ng/ml Hydrocortisone	50% FBS, 40% complete media, 10% DMSO	NA	NAMDA-MB-134-VI	Breast	NA	Breast	Carcinoma	47	Years	Female	Caucasian	334	TRUE	DMEM, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-134-VI	MDA-MB-134-VIMDA-MB-157	Breast	Effusion, Pleural	Breast	Carcinoma Medullary	44	Years	Female	African	540	TRUE	DMEM, 20%FBS, 2mM L-glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-157	MDA-MB-157MDA-MB-175-VII	Breast	NA	Breast	Adenocarcinoma Ductal	56	Years	Female	African	333	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-175-VII	MDA-MB-175-VIIMDA-MB-231	Breast	Effusion, Pleural	Breast	Adenocarcinoma	51	Years	Female	Caucasian	539	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-231	MDA-MB-231MDA-MB-330	Breast	Effusion, Pleural	Breast	Carcinoma	43	Years	Female	Caucasian	538	TRUE	DMEM, 10% FBS, 2mM L-glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAMDA-MB-361	Breast	NA	Breast	Adenocarcinoma	NA	NA	NA	NA	332	TRUE	Leibovitz's L-15 Medium, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-361	MDA-MB-361MDA-MB-415	Breast	NA	Breast	Adenocarcinoma	38	Years	Female	NA	537	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-415	MDA-MB-415MDA-MB-435	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	400	TRUE	DMEM, 10% FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	MDA-MB-435MDA-MB-436	Breast	Effusion, Pleural	Breast	Adenocarcinoma	43	Years	Female	Caucasian	536	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-436	NAMDA-MB-453	Breast	Effusion, Pericardial	Breast	Carcinoma	NA	NA	Female	Caucasian	535	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-453	MDA-MB-453MDA-MB-468	Breast	NA	Breast	Adenocarcinoma	51	Years	Female	African	331	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDA-MB-468	MDA-MB-468MDST8	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	520	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MDST8	NAME-1	Lymphoid	NA	Bone Marrow	Leukemia Acute Myelogenic	40	Years	Male	Japanese	579	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	ME-1	NAME-180	Cervix	NA	Cervix	Carcinoma	66	Years	Female	Caucasian	267	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	ME-180MEL-HO	Skin	NA	Skin	Melanoma	NA	NA	Female	NA	603	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MEL-HO	MEL-HOMeWo	Skin	NA	Skin	Melanoma	78	Years	Male	Caucasian	126	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MeWo	MewoMFM-223	Breast	Effusion, Pleural	Breast	Adenocarcinoma Ductal	NA	NA	Female	NA	534	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	MFM-223MG-63	Sarcomatoid	NA	Bone	Osteosarcoma	14	Years	Male	Caucasian	302	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MG-63	MG-63MHH-ES-1	Sarcomatoid	NA	Bone	Sarcoma Ewings	12	Years	Male	Caucasian	301	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	MHH-ES-1	MHH-ES-1MHH-NB-11	Brain	NA	Brain	Neuroblastoma	4	Years	Male	Caucasian	214	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MHH-NB-11	MHH-NB-11MHH-PREB-1	Lymphoid	NA	Lymph Node	Lymphoma B-cell	6	Years	Male	Caucasian	472	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	MHH-PREB-1MIA Paca-2	Pancreas	NA	Pancreas	Carcinoma	65	Years	Male	Caucasian	419	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	MIA PaCa-2	MIA-PaCa-2MKN-1	Stomach	NA	Stomach	Carcinoma Adenosquamous	72	Years	Male	NA	591	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MKN1	MKN1MKN-45	Stomach	NA	Stomach	Adenocarcinoma	62	Years	Female	NA	514	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MKN-45	MKN45MKN-7	Stomach	NA	Stomach	Adenocarcinoma Tubular	39	Years	Male	NA	6	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	MKN7	MKN7MKN-74	Stomach	NA	Stomach	Adenocarcinoma	37	Years	Male	Japanese	590	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MKN74	NAML-2	Lymphoid	NA	Bone Marrow	Leukemia Acute Myelogenic	26	Years	Male	NA	299	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	ML-2MM.1S	Lymphoid	NA	Blood	Multiple Myeloma	42	Years	Female	African	377	TRUE	#N/A	#N/A	MM1-S	NAMOLM-16	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	Female	Japanese	578	TRUE	RPMI-1640 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MOLM-16	NAMOLP-2	Lymphoid	NA	Blood	Multiple Myeloma	55	Years	Male	NA	348	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MOLP-2	NAMOLP-8	Lymphoid	NA	Blood	Multiple Myeloma	52	Years	Male	Japanese	376	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MOLP-8	NAMOR	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	186	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MOR/CPR	NAMS751	Cervix	NA	Cervix	Carcinoma	47	Years	Female	Caucasian	266	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAMT-3	Breast	NA	Breast	Carcinoma	NA	NA	NA	NA	175	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAMV-4-11	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	10	Years	Male	NA	577	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	MV-4-11	NAMX-1	Breast	NA	Breast	Carcinoma	NA	NA	NA	NA	330	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANALM-6	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	306	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NALM-6	NALM-6NAMALWA	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	NA	NA	NA	NA	471	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NAMALWA	NANCI-H1048	Lung	Effusion, Pleural	Lung	Carcinoma Small Cell	NA	NA	Female	NA	500	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1048	NCI-H1048NCI-H1092	Lung	NA	Lung	Carcinoma Small Cell	67	Years	Male	Caucasian	3	TRUE	HITES, 5% FBS	Complete growth medium, 90%; DMSO, 10%	NCI-H1092	NCI-H1092NCI-H1155	Lung	NA	Lung	Carcinoma Non-Small Cell	36	Years	Male	Caucasian	208	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1155	NCI-H1155NCI-H1299	Lung	NA	Lung	Carcinoma Non-Small Cell	43	Years	Male	Caucasian	388	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1299	NCI-H1299NCI-H1355	Lung	Pleura	Lung	Adenocarcinoma	53	Years	Male	Caucasian	507	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NCI-H1355	NCI-H1355NCI-H1373	Lung	NA	Lung	Adenocarcinoma	56	Years	Male	African	506	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1373	NANCI-H1395	Lung	NA	Lung	Adenocarcinoma	55	Years	Female	Caucasian	93	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NCI-H1395	NCI-H1395NCI-H1435	Lung	NA	Lung	Carcinoma Non-Small Cell	35	Years	Female	NA	499	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1435	NANCI-H1437	Lung	Effusion, Pleural	Lung	Carcinoma Non-Small Cell	60	Years	Male	Caucasian	149	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1437	NCI-H1437NCI-H146	Lung	NA	Lung	Carcinoma Small Cell	NA	NA	Male	Caucasian	234	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H146	NCI-H146NCI-H1568	Lung	NA	Lung	Carcinoma Non-Small Cell	48	Years	Female	Caucasian	498	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1568	NANCI-H1573	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	505	TRUE	ACL-4 media	Complete growth medium, 90%; DMSO, 10%	NCI-H1573	NCI-H1573NCI-H1581	Lung	NA	Lung	Carcinoma Non-Small Cell	44	Years	Male	Caucasian	233	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1581	NANCI-H1623	Lung	NA	Lung	Carcinoma Non-Small Cell	58	Years	Male	Caucasian	92	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1623	NANCI-H1648	Lung	NA	Lung	Adenocarcinoma	39	Years	Male	African	185	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1648	NANCI-H1650	Lung	Effusion, Pleural	Lung	Adenocarcinoma	27	Years	Male	Caucasian	497	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1650	NCI-H1650NCI-H1651	Lung	NA	Lung	Carcinoma Non-Small Cell	71	Years	Male	NA	91	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NCI-H1651	NCI-H1651NCI-H1666	Lung	Effusion, Pleural	Lung	Adenocarcinoma	50	Years	Female	Caucasian	496	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1666	NCI-H1666NCI-H1693	Lung	NA	Lung	Carcinoma Non-Small Cell	55	Years	Female	Caucasian	504	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1693	NCI-H1693NCI-H1703	Lung	NA	Lung	Carcinoma Non-Small Cell	54	Years	Male	Caucasian	363	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1703	NCI-H1703NCI-H1734	Lung	NA	Lung	Carcinoma Non-Small Cell	56	Years	Female	NA	184	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1734	NANCI-H1770	Lung	NA	Lung	Carcinoma Non-Small Cell	57	Years	NA	Caucasian	394	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NCI-H1770NCI-H1781	Lung	Effusion, Pleural	Lung	Adenocarcinoma	66	Years	Female	Caucasian	362	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1781	NANCI-H1792	Lung	NA	Lung	Adenocarcinoma	50	Years	Male	Caucasian	503	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1792	NCI-H1792NCI-H1793	Lung	NA	Lung	Adenocarcinoma	52	Years	Female	NA	495	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1793	NCI-H1793NCI-H1838	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	Female	NA	494	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1838	NCI-H1838NCI-H1869	Lung	NA	Lung	Carcinoma Non-Small Cell	58	Years	Male	Caucasian	90	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1869	NANCI-H187	Lung	NA	Lung	Carcinoma Small Cell	47	Years	Male	Caucasian	89	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NANCI-H1882	Lung	NA	Lung	Carcinoma Small Cell	59	Years	Male	Caucasian	53	TRUE	HITES, 5% FBS	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H1915	Lung	NA	Lung	Carcinoma Non-Small Cell	61	Years	Female	Caucasian	183	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1915	NANCI-H1930	Lung	NA	Lung	Carcinoma Small Cell	41	Years	Male	Caucasian	88	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1930	NCI-H1930NCI-H1944	Lung	Soft Tissue	Lung	Carcinoma Non-Small Cell	62	Years	Female	Caucasian	493	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1944	NANCI-H196	Lung	Pleura	Lung	Carcinoma Small Cell	68	Years	Male	Caucasian	182	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H196	NANCI-H1975	Lung	NA	Lung	Adenocarcinoma	NA	NA	Female	NA	361	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H1975	NCI-H1975NCI-H2009	Lung	NA	Lung	Adenocarcinoma	68	Years	NA	Caucasian	360	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2009	NCI-H2009NCI-H2023	Lung	Lymph Node	Lung	Carcinoma Non-Small Cell	26	NA	Male	Caucasian	148	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2023	NANCI-H2030	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	Male	NA	492	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2030	NCI-H2030NCI-H2052	Other	NA	Pleura	Mesothelioma	NA	NA	NA	NA	83	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2052	NCI-H2052NCI-H2073	Lung	NA	Lung	Adenocarcinoma	47	Years	Female	Caucasian	385	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2073	NANCI-H2081	Lung	NA	Lung	Carcinoma Small Cell	59	Years	Female	Caucasian	2	TRUE	HITES, 5% FBS	Complete growth medium, 90%; DMSO, 10%	NCI-H2081	NCI-H2081NCI-H209	Lung	NA	Lung	Carcinoma Small Cell	NA	NA	Male	Caucasian	87	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H209	NCI-H209NCI-H2106	Lung	Lymph Node	Lung	Carcinoma Non-Small Cell	58	Years	Male	Caucasian	394	FALSE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2106	NANCI-H2110	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	232	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2110	NANCI-H2122	Lung	Effusion, Pleural	Lung	Carcinoma Non-Small Cell	46	Years	Female	Caucasian	358	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NCI-H2122	NANCI-H2126	Lung	Effusion, Pleural	Lung	Carcinoma Non-Small Cell	65	Years	Male	Caucasian	343	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2126	NCI-H2126NCI-H2135	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	147	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2170	Lung	NA	Lung	Carcinoma Squamous Cell	NA	NA	Male	NA	146	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NCI-H2170	NCI-H2170NCI-H2171	Lung	Effusion, Pleural	Lung	Carcinoma Small Cell	50	Years	Male	Caucasian	86	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2171	NCI-H2171NCI-H2172	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	Female	NA	9	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2172	NANCI-H2196	Lung	NA	Lung	Carcinoma Small Cell	67	Years	Male	Caucasian	11	FALSE	DMEM:F12, 5% FBS, 0.005 mg/ml insulin, 0.01 mg/ml Transferrin, 30nM Sodium selenite, 10nM Hydrocortisone, 10nM beta-estradiol, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2196	NCI-H2196NCI-H2198	Lung	NA	Lung	Carcinoma Small Cell	67	Years	Male	Caucasian	11	TRUE	DMEM:F12, 5% FBS, 0.005 mg/ml insulin, 0.01 mg/ml Transferrin, 30nM Sodium selenite, 10nM Hydrocortisone, 10nM beta-estradiol, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2228	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	Female	NA	342	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2228	NCI-H2228NCI-H226	Lung	Ascites	Lung	Mesothelioma	NA	NA	Male	NA	386	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H226	NCI-H226NCI-H23	Lung	NA	Lung	Carcinoma Non-Small Cell	51	Years	Male	African	226	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H23	NCI-H23NCI-H2347	Lung	NA	Lung	Carcinoma Non-Small Cell	54	Years	Female	Caucasian	181	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2347	NCI-H2347NCI-H2369	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	78	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2373	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	82	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2452	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	81	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H2452	NCI-H2452NCI-H2461	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	84	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2595	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	79	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2596	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	NA	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2722	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	75	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2795	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	31	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H28	Other	NA	Pleura	Mesothelioma	NA	NA	NA	NA	80	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H28	NCI-H28NCI-H2803	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	77	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2804	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	76	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H2810	Lung	NA	Lung	Mesothelioma	NA	NA	NA	NA	55	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H292	Lung	NA	Lung	Carcinoma Mucoepidermoid	32	Years	Female	African	357	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H292	NCI-H292NCI-H322T	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	145	TRUE	RPMI-1640 10% FBS; 2mM L-Glutamine	90% FBS; 10% DMSO	NA	NANCI-H345	Lung	NA	Lung	Carcinoma Small Cell	64	Years	Male	Caucasian	85	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NCI-H345NCI-H358	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	387	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H358	NCI-H358NCI-H441	Lung	NA	Lung	Adenocarcinoma Papillary	NA	NA	Male	NA	356	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H441	NCI-H441NCI-H446	Lung	NA	Lung	Carcinoma Small Cell	61	Years	Male	Caucasian	231	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H446	NCI-H446NCI-H460	Lung	Effusion, Pleural	Lung	Carcinoma Large Cell	NA	NA	Male	NA	355	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H460	NCI-H460NCI-H510A	Lung	NA	Lung	Carcinoma Small Cell	56	Years	Male	Caucasian	1	TRUE	F-12K, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H510	NCI-H510ANCI-H520	Lung	NA	Lung	Carcinoma Squamous Cell	NA	NA	Male	NA	354	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H520	NCI-H520NCI-H522	Lung	NA	Lung	Carcinoma Non-Small Cell	58	Years	Male	Caucasian	341	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H522	NCI-H522NCI-H596	Lung	NA	Lung	Carcinoma Adenosquamous	73	Years	Male	Caucasian	340	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H596	NCI-H596NCI-H650	Lung	Lymph Node	Lung	Carcinoma Non-Small Cell	NA	NA	Male	NA	389	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H650	NCI-H650NCI-H716	Colo-Rectal	NA	Cecum	Adenocarcinoma	NA	NA	Male	Caucasian	100	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NCI-H716	NCI-H716NCI-H727	Lung	NA	Lung	Tumor Carcinoid	65	Years	Female	Caucasian	144	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H727	NCI-H727NCI-H810	Lung	NA	Lung	Carcinoma Non-Small Cell	51	Years	Male	African	180	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H810	NCI-H810NCI-H82	Lung	NA	Lung	Carcinoma Small Cell	40	Years	NA	Caucasian	143	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H82	NCI-H82NCI-H820	Lung	NA	Lung	Adenocarcinoma	NA	NA	Male	Caucasian	179	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H847	Lung	NA	Lung	Carcinoma Small Cell	63	Years	Male	Caucasian	10	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H889	Lung	NA	Lung	Carcinoma Small Cell	NA	NA	Female	Caucasian	230	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H889	NCI-H889NCI-H920	Lung	Lymph Node	Lung	Carcinoma Non-Small Cell	43	Years	Male	Caucasian	178	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANCI-H929	Lymphoid	NA	Bone Marrow	Multiple Myeloma	NA	NA	NA	NA	374	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NCI-H929	NANCI-N417	Lung	NA	Lung	Carcinoma Small Cell	NA	NA	NA	NA	142	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NCI-N417NCI-N87	Stomach	Liver	Stomach	Carcinoma	NA	NA	NA	NA	598	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	NCI-N87	NCI-N87NIH:OVCAR-3	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	Female	Caucasian	29	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NIH:OVCAR-3	OVCAR-3NTERA-2	Other	NA	Testis	Carcinoma	22	Years	Male	Caucasian	121	TRUE	McCoys 5A, 15% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NANU-DUL-1	Lymphoid	NA	Blood	Lymphoma B-cell	NA	NA	NA	NA	470	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NU-DUL-1	NANUGC-2	Stomach	NA	Stomach	Adenocarcinoma	56	Years	Female	NA	589	TRUE	RPMI-1640, 15% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NUGC-2	NANUGC-3	Stomach	NA	Stomach	Adenocarcinoma	72	Years	Male	NA	588	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NUGC-3	NUGC-3NUGC-4	Stomach	NA	Stomach	Adenocarcinoma	35	Years	Female	NA	587	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NUGC-4	NAOAW28	Ovary	NA	Ovary	Cystadenocarcinoma Serous	NA	NA	Female	NA	436	TRUE	DMEM, 10% FBS, 2mM Gln, 1mM NaP, 20IU/L Bovine Insulin	Complete growth medium, 90%; DMSO, 10%	OAW28	OAW-28OAW42	Ovary	NA	Ovary	Cystadenocarcinoma Serous	NA	NA	NA	NA	435	TRUE	DMEM, 10% FBS, 2mM Gln, 1mM NaP, 20IU/L Bovine Insulin	Complete growth medium, 90%; DMSO, 10%	OAW42	OAW-42OCI-AML2	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	576	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OCI-AML2	OCI-AML2OCI-AML3	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	575	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OCI-AML3	NAOCI-AML5	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	77	Years	Male	NA	574	TRUE	RPMI-1640 + 10% HI FBS + 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OCI-AML5	NAOCI-LY-10	Lymphoid	NA	Lymph Node	Lymphoma B-cell	NA	NA	NA	NA	469	TRUE	IMDM, 20% Fresh Human Serum, 2mM L-Glutamine, 50 uM 2-Mercaptoethanol	Complete growth medium, 90%; DMSO, 10%	OCI-LY10	NAOCI-LY-19	Lymphoid	NA	Lymph Node	Lymphoma B-cell	27	Years	Female	NA	468	TRUE	alpha-MEM, 10% HI FBS, 2mM Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	OCI-LY-19	NAOCI-LY-3	Lymphoid	NA	Lymph Node	Lymphoma B-cell	NA	NA	NA	NA	467	TRUE	IMDM, 20% Fresh Human Serum, 2mM L-Glutamine, 50 uM 2-Mercaptoethanol	Complete growth medium, 90%; DMSO, 10%	OCI-LY3	NAOCI-LY-7	Lymphoid	NA	Lymph Node	Lymphoma B-cell	NA	NA	NA	NA	466	TRUE	#N/A	#N/A	NA	NAOCI-M1	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	573	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OCI-M1	NAOCI-M2	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	572	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAOCUM-1	Stomach	NA	Stomach	Adenocarcinoma	38	Years	NA	Japanese	592	TRUE	DMEM, 10% FBS, 2mM L-Glutamine, 0.5mM NaP	Complete growth medium, 90%; DMSO, 10%	OCUM-1	NAOkajima	Stomach	NA	Stomach	Adenocarcinoma	NA	NA	NA	NA	513	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAOPM-2	Lymphoid	NA	Blood	Multiple Myeloma	56	Years	Female	NA	373	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OPM-2	OPM-2OUMS-23	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Male	NA	260	TRUE	DMEM, 10% FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	OUMS-23	NAOV-90	Ovary	NA	Ovary	Adenocarcinoma Papillary Serous	NA	NA	Female	Caucasian	137	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; DMSO, 10%	OV-90	NAOV56	Ovary	NA	Ovary	Carcinoma	46	Years	Female	NA	434	TRUE	DMEM:Hams F12 (1:1), 5% FBS, 2mM Gln, 0.5ug/ml hydrocortisone, 10ug/ml insulin	90% FBS; 10% DMSO	OV56	NAOV7	Ovary	NA	Ovary	Carcinoma	78	Years	Female	NA	138	TRUE	DMEM:HAMS F12 (1:1), 2mM Glutamine, 5% FBS, 0.5 ug/ml hydrocortisone, 10ug/ml insulin	Complete growth medium, 90%; DMSO, 10%	OV7	NAOVCA 420	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	433	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NA	NAOvCA 429	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	Female	NA	393	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAOvCA 432	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	136	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAOVCAR-4	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	Female	NA	432	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OVCAR-4	OVCAR-4OVCAR-5	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	Female	NA	431	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	OVCAR-5OVCAR-8	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	Female	NA	430	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10%DMSO	OVCAR-8	OVCAR-8OVCAR433	Ovary	NA	Ovary	Carcinoma	NA	NA	Female	NA	393	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	FBS, 90%; DMSO, 10%	NA	NAOVISE	Ovary	NA	Ovary	Adenocarcinoma Clear Cell	40	Years	Female	Japanese	47	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OVISE	NAOVKATE	Ovary	NA	Ovary	Adenocarcinoma Papillary Serous	40	Years	Female	Japanese	21	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OVKATE	NAOVMANA	Ovary	NA	Ovary	Adenocarcinoma Clear Cell	NA	NA	NA	NA	20	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OVMANA	NAOVSAHO	Ovary	NA	Ovary	Adenocarcinoma Papillary Serous	NA	NA	NA	NA	28	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OVSAHO	NAOVTOKO	Ovary	NA	Ovary	Adenocarcinoma Clear Cell	78	Years	Female	Japanese	52	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	OVTOKO	NAPA-1	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	225	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	NA	PA-1PA-TU-8902	Pancreas	NA	Pancreas	Adenocarcinoma	NA	NA	NA	NA	412	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PA-TU-8902	NAPA-TU-8988S	Pancreas	NA	Pancreas	Adenocarcinoma	64	Years	Female	NA	318	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PA-TU-8988S	NAPA-TU-8988T	Pancreas	NA	Pancreas	Adenocarcinoma	64	Years	Female	NA	318	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PA-TU-8988T	NAPanc 02.03	Pancreas	NA	Pancreas	Adenocarcinoma	70	Years	Female	Caucasian	418	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Panc 02.03	NAPanc 03.27	Pancreas	NA	Pancreas	Adenocarcinoma	65	Years	Female	Caucasian	417	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Panc 03.27	PANC-03-27Panc 04.03	Pancreas	NA	Pancreas	Adenocarcinoma	70	Years	Male	Caucasian	416	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Panc 04.03	NAPanc 05.04	Pancreas	NA	Pancreas	Adenocarcinoma	77	Years	Female	Caucasian	415	TRUE	RPMI-1640, 15% FBS, 20 U/ml human recombinant insulin, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Panc 05.04	NAPanc 08.13	Pancreas	NA	Pancreas	Adenocarcinoma	85	Years	Male	Caucasian	414	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Panc 08.13	PANC-08-13PANC-1	Pancreas	Soft Tissue	Pancreas	Adenocarcinoma	56	Years	Male	Caucasian	413	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PANC-1	NAPC-3	Other	NA	Prostate	Adenocarcinoma	62	Years	Male	Caucasian	133	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PC-3	PC-3PE/CA-PJ15	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	NA	NA	NA	NA	119	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PE/CA-PJ15	NAPE01	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	NA	NA	135	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAPfeiffer	Lymphoid	NA	Blood	Hodgkin's Lymphoma	NA	NA	NA	NA	465	TRUE	#N/A	#N/A	Pfeiffer	NAPK-45H	Pancreas	NA	Pancreas	Carcinoma	NA	NA	NA	NA	317	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PK-45H	NAPK-45P	Pancreas	NA	Pancreas	Carcinoma	NA	NA	NA	NA	317	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAPK-59	Pancreas	NA	Pancreas	Carcinoma	NA	NA	NA	NA	316	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PK-59	NAPK-8	Pancreas	NA	Pancreas	Carcinoma	NA	NA	NA	NA	315	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAPL-21	Lymphoid	NA	Blood	Leukemia	24	Years	Male	NA	392	TRUE	RPMI-1640; 10% HI FBS; 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PL-21	NAPL45	Pancreas	NA	Pancreas	Adenocarcinoma Ductal	NA	NA	Male	Caucasian	411	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PL45	NAPLC/PRF/5	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	249	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PLC/PRF/5	PLC-PRF-5PSN1	Pancreas	NA	Pancreas	Adenocarcinoma	NA	NA	NA	NA	69	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	PSN1	PSN1QGP-1	Pancreas	NA	Pancreas	Carcinoma Islet Cell	NA	NA	NA	NA	314	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	QGP-1	NARAJI	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	11	Years	Male	African	464	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Raji	RajiRAMOS	Lymphoid	NA	Blood	Malignant Lymphoma - Burkitts Type	3	Years	Male	NA	463	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	Complete Growth Media, 90%; DMSO, 10%	NA	NARC-K8	Lymphoid	NA	Blood	Lymphoma B-cell	NA	NA	NA	NA	462	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NARCM-1	Colo-Rectal	NA	Colon	Adenocarcinoma	73	Years	Female	NA	38	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RCM-1	RCM-1REC-1	Lymphoid	NA	Lymph Node	Lymphoma B-cell	61	Years	Male	NA	461	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	70% RPMI, 20% HI FBS, 10% DMSO	REC-1	NARERF-GC-1B	Stomach	NA	Stomach	Carcinoma	41	Years	Male	Japanese	586	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RERF-GC-1B	NARERF-LC-KJ	Lung	NA	Lung	Adenocarcinoma	78	Years	Male	NA	339	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RERF-LC-KJ	NARERF-LC-MS	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	NA	NA	491	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RERF-LC-MS	RERF-LC-MSRERF-LC-OK	Lung	NA	Lung	Adenocarcinoma	NA	NA	NA	NA	338	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NARI-1	Lymphoid	NA	Lymph Node	Lymphoma B-cell	57	Years	Female	NA	460	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	RI-1	NARKN	Ovary	NA	Ovary	Leiomyosarcoma	45	Years	Female	Japanese	40	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RKN	NARKO	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	259	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	RKO	RKORKO-E6	Colo-Rectal	NA	Colon	Carcinoma	NA	NA	NA	NA	259	FALSE	EMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NARL	Lymphoid	NA	Lymph Node	Lymphoma B-cell	52	Years	Male	NA	459	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	RPMI 1640, 20% HI FBS, 10% DMSO	RL	RLRMG-I	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	37	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RMG-I	RMG-IRMUG-S	Ovary	NA	Ovary	Adenocarcinoma	62	Years	Female	Japanese	36	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RMUG-S	NARPMI 2650	Colo-Rectal	NA	Septum	Carcinoma Squamous Cell	52	Years	Male	NA	131	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	RPMI-2650RPMI 8226	Lymphoid	NA	Blood	Multiple Myeloma	NA	NA	NA	NA	372	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RPMI 8226	RPMI-8226RPMI-7951	Skin	NA	Skin	Melanoma	18	Years	NA	Caucasian	399	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RPMI-7951	RPMI-7951RT-112	Urinary Bladder	NA	Urinary Bladder	Carcinoma Transitional Cell	NA	NA	Female	NA	254	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RT-112	RT-112RT4	Urinary Bladder	NA	Urinary Bladder	Carcinoma Transitional Cell	63	Years	Male	Caucasian	253	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	RT4	NASC-1	Lymphoid	NA	Lymph Node	Lymphoma B-cell	67	Years	Male	NA	458	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	Complete Growth Media, 90%; DMSO, 10%	NA	NASCC-15	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	NA	NA	NA	NA	109	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SCC-15	SCC-15SCC-25	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	NA	NA	NA	NA	197	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SCC-25	SCC-25SCC-3	Lymphoid	NA	Blood	Lymphoma Non-Hodgkins	20	Years	NA	NA	457	TRUE	RPMI-1640 10% Heat Inactivated FBS, 2mM Glutamine	Complete Growth Media, 90%; DMSO, 10%	NA	SCC-3SCC-9	Head-Neck	NA	Tongue	Carcinoma Squamous Cell	25	Years	Male	NA	108	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SCC-9	SCC-9SCLC-21H	Lung	NA	Lung	Carcinoma Small Cell	46	Years	Male	Caucasian	229	FALSE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SCLC-21H	SCLC-21HSCLC-22H	Lung	NA	Lung	Carcinoma Small Cell	46	Years	Male	Caucasian	229	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASET-2	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	61	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	Set-2	NASF268	Brain	NA	Brain	Glioma	NA	NA	NA	NA	278	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NA	SF268SF539	Brain	NA	Brain	Glioma	NA	NA	NA	NA	277	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	NA	SF539SIG-M5	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	NA	NA	NA	NA	305	TRUE	RPMI-1640, 20% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SIG-M5	NASiHa	Cervix	NA	Cervix	Carcinoma Squamous Cell	NA	NA	NA	NA	265	TRUE	RPMI-1640, 10% FBS, L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	SiHaSJCRH30	Sarcomatoid	NA	Skeletal Muscle	Rhabdomyosarcoma	17	Years	Male	Caucasian	130	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASK-BR-3	Breast	NA	Breast	Adenocarcinoma	43	Years	Female	Caucasian	533	TRUE	DMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-BR-3	NASK-CO-1	Colo-Rectal	NA	Colon	Adenocarcinoma	65	Years	Male	Caucasian	519	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS, 10% DMSO	SK-CO-1	SK-CO-1SK-MEL-1	Skin	Lymphatic Tissue	Skin	Melanoma Metastatic	29	Years	Male	Caucasian	602	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MEL-1	NASK-MEL-2	Skin	NA	Skin	Melanoma	60	Years	Male	Caucasian	397	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MEL-2	SK-MEL-2SK-MEL-24	Skin	Lymph Node	Skin	Melanoma	67	Years	Male	Caucasian	200	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	SK-MEL-24	SK-MEL-24SK-MEL-28	Skin	NA	Skin	Melanoma	51	Years	Male	NA	398	TRUE	DMEM, 10% FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MEL-28	SK-MEL-28SK-MEL-3	Skin	NA	Skin	Melanoma	42	Years	Female	Caucasian	25	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MEL-3	SK-MEL-3SK-MEL-30	Skin	NA	Skin	Melanoma	67	Years	Male	Caucasian	601	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MEL-30	SK-MEL-30SK-MEL-31	Skin	NA	Skin	Melanoma	NA	NA	Female	NA	7	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MEL-31	NASK-MEL-5	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	396	TRUE	#N/A	#N/A	SK-MEL-5	SK-MEL-5SK-MES-1	Lung	Effusion, Pleural	Lung	Carcinoma Squamous Cell	65	Years	Male	Caucasian	490	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MES-1	SK-MES-1SK-MM-2	Lymphoid		Blood	Leukemia	NA	NA	NA	NA	18	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-MM-2	SK-MM-2SK-N-AS	Brain	NA	Brain	Neuroblastoma	NA	NA	NA	NA	276	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	SK-N-AS	SK-N-ASSK-N-DZ	Brain	NA	Brain	Neuroblastoma	2	Years	Female	Caucasian	275	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-N-DZ	SK-N-DZSK-N-FI	Brain	NA	Brain	Neuroblastoma	11	Years	Male	Caucasian	274	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-N-FI	SK-N-FISK-N-SH	Brain	NA	Brain	Neuroblastoma	4	Years	Female	NA	60	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-N-SH	NASK-OV-3	Ovary	NA	Ovary	Adenocarcinoma	NA	NA	Female	Caucasian	429	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SK-OV-3	SK-OV-3SK23	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	222	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASKM-1	Lymphoid	NA	Blood	Myelodysplasia	NA	NA	NA	NA	571	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SKM-1	SKM-1SNU-1	Stomach	NA	Stomach	Carcinoma	NA	NA	NA	NA	597	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-1	NCI-SNU-1SNU-16	Stomach	Ascites	Stomach	Carcinoma	33	Years	Female	NA	595	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-16	NCI-SNU-16SNU-182	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	59	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-182	NASNU-216	Stomach	Lymph Node	Stomach	Carcinoma	46	Years	Female	NA	125	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-216	NASNU-387	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	248	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	SNU-387	SNU-387SNU-398	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	247	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	SNU-398	NASNU-423	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	158	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	SNU-423	SNU-423SNU-449	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	246	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	SNU-449	SNU-449SNU-475	Liver	NA	Liver	Carcinoma Hepatocellular	NA	NA	NA	NA	245	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine, 100mM HEPES	Complete growth medium, 90%; DMSO, 10%	SNU-475	SNU-475SNU-484	Stomach	NA	Stomach	Carcinoma	53	Years	Male	NA	124	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASNU-5	Stomach	NA	Stomach	Carcinoma	NA	NA	NA	NA	596	TRUE	RPMI-1640, 20% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-5	NCI-SNU-5SNU-601	Stomach	Ascites	Stomach	Carcinoma	34	Years	Male	NA	584	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-601	NASNU-620	Stomach	Ascites	Stomach	Carcinoma	59	Years	Female	NA	219	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-620	NASNU-638	Stomach	Ascites	Stomach	Carcinoma	48	Years	Male	NA	123	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASNU-668	Stomach	Ascites	Stomach	Carcinoma	68	Years	Male	NA	122	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-668	NASNU-719	Stomach	NA	Stomach	Carcinoma	53	Years	Male	NA	218	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-719	NASNU-C1	Colo-Rectal	NA	Colon	Adenocarcinoma	71	Years	Male	NA	258	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SNU-C1	SNU-C1SR	Lymphoid	NA	Lymph Node	Lymphoma Immunoblastic Large Cell	11	Years	Male	NA	141	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	RPMI, 20% FBS, 10% DMSO	SR-786	SRSR-786	Lymphoid	NA	Blood	Lymphoma Anaplastic Large Cell	NA	NA	NA	NA	141	FALSE	#N/A	#N/A	SR-786	SRSU-DHL-1	Lymphoid	NA	Lymph Node	Lymphoma Non-Hodgkins	10	Years	Male	NA	456	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	SU-DHL-1	SU-DHL-1SU-DHL-10	Other	NA	Pleura	Lymphoma B-cell	NA	NA	Male	NA	455	TRUE	90% RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SU-DHL-10	NASU-DHL-16	Lymphoid	NA	Lymph Node	Lymphoma B-cell	NA	NA	Male	NA	454	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASU-DHL-4	Lymphoid	NA	Lymph Node	Lymphoma B-cell	38	Years	Male	NA	453	TRUE	RPMI-1640 10% HI FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	SU-DHL-4	NASU-DHL-5	Lymphoid	NA	Lymph Node	Lymphoma B-cell	17	Years	Female	NA	452	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	Complete Growth Media, 90%; DMSO, 10%	SU-DHL-5	NASU-DHL-6	Lymphoid	NA	Lymph Node	Lymphoma	NA	NA	NA	NA	451	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	HI FBS, 90%; DMSO, 10%	SU-DHL-6	NASU-DHL-8	Lymphoid	NA	Lymph Node	Lymphoma B-cell	59	Years	Male	NA	450	TRUE	RPMI-1640 20% HI FBS, 2mM Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	SU-DHL-8	NASU.86.86	Pancreas	NA	Pancreas	Adenocarcinoma Ductal	57	Years	Female	Caucasian	410	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	SU.86.86	NASUIT-2	Pancreas	NA	Pancreas	Adenocarcinoma Tubular	73	Years	Male	Japanese	313	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SUIT-2	NASUM 1315M02	Breast	NA	Breast	Adenocarcinoma Ductal	NA	NA	NA	NA	329	TRUE	Ham's F-12, 5% FBS, Insulin (5ug/ml), EGF (10ng/ml), 10mM HEPES, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASUM 149PT	Breast	NA	Breast	Adenocarcinoma Ductal	NA	NA	Female	NA	328	TRUE	Ham's F-12, 5% FBS, Insulin (5ug/ml) and Hydrocortisone (1ug/ml), 10mM HEPES, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASUM 159PT	Breast	NA	Breast	Anaplastic Carcinoma	NA	NA	Female	NA	327	TRUE	Ham's F-12, 5% FBS, Insulin (5ug/ml) and Hydrocortisone (1ug/ml), 10mM HEPES, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASUM 229PE	Breast	Pleura	Breast	Carcinoma	NA	NA	Female	NA	328	FALSE	Ham's F-12, 5% FBS, Insulin (5ug/ml) and Hydrocortisone (1ug/ml), 10mM HEPES, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASUM 52PE	Breast	NA	Breast	Carcinoma	NA	NA	NA	NA	326	TRUE	Ham's F-12, 5% FBS, Insulin (5ug/ml) and Hydrocortisone (1ug/ml), 10mM HEPES, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NASUP-B15	Lymphoid	NA	Blood	Leukemia Acute Lymphocytic	NA	NA	NA	NA	570	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SUP-B15	NASW 1116	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	518	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW1116	SW1116SW 1417	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	Female	Caucasian	212	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS, 10% DMSO	SW1417	SW1417SW 1463	Colo-Rectal	NA	Colon	Adenocarcinoma	66	Years	Female	Caucasian	174	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% Complete Growth Media, 10% DMSO	SW1463	SW1463SW 1573	Lung	NA	Lung	Adenocarcinoma Bronchioloalveolar	44	Years	Female	Caucasian	352	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW 1573	SW1573SW 1990	Pancreas	NA	Pancreas	Adenocarcinoma	56	Years	Male	Caucasian	409	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW 1990	SW1990SW 403	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	517	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW403	SW403SW 48	Colo-Rectal	NA	Colon	Adenocarcinoma	82	Years	Female	Caucasian	173	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW48	SW48SW 480	Colo-Rectal	NA	Colon	Adenocarcinoma	50	Years	Male	Caucasian	54	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	SW480	NASW 527	Breast	NA	Breast	Adenocarcinoma	NA	NA	Female	Caucasian	54	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW579	NASW 620	Colo-Rectal	NA	Colon	Adenocarcinoma	51	Years	Male	Caucasian	54	FALSE	Leibovitz's L-15 Medium, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW620	SW620SW 780	Urinary Bladder	NA	Urinary Bladder	Carcinoma Transitional Cell	80	Years	Female	Caucasian	168	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW 780	SW780SW 837	Colo-Rectal	NA	Rectum	Adenocarcinoma	53	Years	Male	Caucasian	132	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	90% FBS; 10% DMSO	SW837	SW837SW 900	Lung	NA	Lung	Carcinoma Non-Small Cell	NA	NA	Male	Caucasian	17	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW 900	SW900SW 948	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	516	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	SW948	SW948SW 982	Breast	NA	Breast	Sarcoma Synovial	25	Years	Female	Caucasian	272	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	SW982T-47D	Breast	NA	Breast	Adenocarcinoma Ductal	54	Years	Female	NA	532	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	T-47D	T47DT84	Colo-Rectal	Lung	Colon	Carcinoma	NA	NA	NA	NA	515	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	T84	T84T98G	Brain	NA	Brain	Glioblastoma	61	Years	Male	Caucasian	273	TRUE	EMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	T98G	T98GTC-71	Sarcomatoid	NA	Bone	Sarcoma Ewings	22	Years	Male	NA	300	TRUE	RPMI-1640 10% FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	TC-71	NATCC-PAN2	Pancreas	NA	Pancreas	Carcinoma	68	Years	Female	Japanese	312	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	TCC-PAN2	NATHP-1	Lymphoid	NA	Blood	Leukemia Acute Myelogenic	1	Years	Male	NA	23	TRUE	RPMI-1640 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	THP-1	THP-1TK	Lymphoid	NA	Blood	Lymphoma	NA	NA	NA	NA	449	TRUE	#N/A	#N/A	NA	NATK-10	Kidney	NA	Kidney	Carcinoma	46	Years	Male	NA	163	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	TK10TMD8	Lymphoid	NA	Blood	Lymphoma Diffuse Large B Cell	62	Years	Male	NA	448	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAToledo	Lymphoid	Effusion, Pleural	Lymph Node	Lymphoma B-cell	NA	NA	Female	Caucasian	447	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	complete growth media 10% DMSO	Toledo	NATOV-112D	Ovary	NA	Ovary	Adenocarcinoma Endometrioid	42	Years	Female	Caucasian	428	TRUE	RPMI-1640 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	TOV-112D	NATYK-nu	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	41	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	TYK-nu	TYK-nuTYK-nu.CP-r	Ovary	NA	Ovary	Carcinoma	NA	NA	NA	NA	41	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAU-2 OS	Sarcomatoid	NA	Bone	Osteosarcoma	15	Years	Female	Caucasian	391	TRUE	DMEM:F12, 10% FBS, 2mM Glutamine	Complete growth medium, 90%; DMSO, 10%	U-2 OS	U-2-OSU-2932	Lymphoid	NA	Blood	Lymphoma B-cell	NA	NA	NA	NA	445	TRUE	#N/A	#N/A	NA	NAU-698-M	Lymphoid	NA	Lymph Node	Lymphoma B-cell	7	Years	Male	NA	446	TRUE	RPMI-1640 10% HI FBS, 2mM Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	NA	U-698-MU-937	Lymphoid	NA	Blood	Lymphoma Diffuse Large B Cell	37	Years	Male	Caucasian	304	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	U-937	NAU266B1	Lymphoid	NA	Blood	Multiple Myeloma	NA	NA	NA	NA	347	TRUE	RPMI-1640, 10% Heat inactivated FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	U266B1	U-266UACC-257	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	395	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	UACC-257	UACC-257UACC-812	Breast	NA	Breast	Adenocarcinoma Ductal	43	Years	Female	NA	531	TRUE	L-15, 20% FBS, 2mM L-Glutamine, 20ng/ml EGF	Complete growth medium, 90%; DMSO, 10%	UACC-812	UACC-812UACC-893	Breast	NA	Breast	Adenocarcinoma Ductal	57	Years	Female	Caucasian	NA	TRUE	Leibovitz's L-15, 20% FBS, 2mM L-glutamine, 10ng/ml EGF	Complete growth medium, 90%; DMSO, 10%	UACC-893	NAUCSD-242l	Skin	NA	Skin	Melanoma	NA	NA	NA	NA	118	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAUKE-1	Lymphoid	NA	Blood	Leukemia	NA	NA	NA	NA	58	TRUE	RPMI-1640, 10% Heat Inactivated FBS, 2mM L-Gln	Complete growth medium, 90%; DMSO, 10%	NA	NAUM-UC-1	Urinary Bladder	NA	Urinary Bladder	Carcinoma Transitional Cell	NA	NA	NA	NA	216	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	UM-UC-1	NAUM-UC-3	Urinary Bladder	NA	Urinary Bladder	Carcinoma Transitional Cell	NA	NA	Male	NA	215	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	UM-UC-3	UM-UC-3UMC-11	Lung	NA	Lung	Tumor Carcinoid	NA	NA	NA	NA	57	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	UMC-11VMRC-LCD	Lung	NA	Lung	Adenocarcinoma	NA	NA	Male	NA	337	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	VMRC-LCD	NAWiDr	Colo-Rectal	NA	Colon	Adenocarcinoma	NA	NA	NA	NA	172	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAWM-115	Skin	NA	Skin	Melanoma	58	Years	Female	NA	221	TRUE	EMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	WM-115	WM-115WM-266-4	Skin	NA	Skin	Melanoma	58	Years	Female	NA	221	FALSE	EMEM, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	WM-266-4	NAWSU-DLCL2	Lymphoid	NA	Lymph Node	Lymphoma B-cell	41	Years	Male	Caucasian	444	TRUE	RPMI-1640; 10% HI FBS; 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	WSU-DLCL2	NAWSU-FSCCL	Lymphoid	NA	Lymph Node	Lymphoma B-cell	37	Years	NA	Caucasian	443	TRUE	RPMI-1640, 10% HI FBS, 2mM Glutamine	RPMI-1640, 20% HI FBS, 10% DMSO	NA	NAWSU-NHL	Lymphoid	NA	Blood	Lymphoma B-cell	NA	NA	NA	NA	442	TRUE	RPMI-1640, 10% HI FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	WSU-NHLYAPC	Pancreas	NA	Pancreas	Carcinoma	43	Years	Male	Japanese	311	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	YAPC	YAPCYMB-1	Breast	NA	Breast	Carcinoma	55	Years	Female	NA	101	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	YMB-1	NAYMB-1-E	Breast	NA	Breast	Carcinoma	55	Years	Female	NA	101	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	NA	NAZR-75-1	Breast	NA	Breast	Adenocarcinoma Ductal	63	Years	NA	Caucasian	101	FALSE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	ZR-75-1	NAZR-75-30	Breast	Ascites	Breast	Adenocarcinoma Ductal	47	Years	Female	African	530	TRUE	RPMI-1640, 10% FBS, 2mM L-Glutamine	Complete growth medium, 90%; DMSO, 10%	ZR-75-30	ZR-75-30